RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R10915 | GSK3235025;EPZ-015666;GSK-3235025 | EPZ015666 is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki |
| R10916 | SKF-86002 | SKF-86002 is a potent inhibitor of p38 MAP kinase wit IC50 of 0.5-1 uM; inhibits |
| R10917 | Radotinib; IY-5511 | Radotinib(IY-5511) is a novel and selective BCR-ABL1 tyrosine kinase inhibitor w |
| R10918 | Liproxstatin-1 | Liproxstatin-1 is a potent ferroptosis inhibitor. |
| R10919 | Defactinib;VS-6063; PF-04554878 | Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antian |
| R10920 | HTH-01-015 | HTH-01-015 is a potent and selective NUAK1 inhibitor with IC50 of 100 nM, >10 |
| R10921 | SD208 | SD-208 is a selective TGF-βRI (ALK5) inhibitor with IC50 of 48 nM, >100-fold |
| R10925 | ML324 | ML324 is a selective inhibitor of jumonji histone demethylase (JMJD2) with IC50 |
| R10926 | ZK-811752; BX 471 | BX471 (ZK-811752) is an orally active, potent and selective non-peptide CCR1 ant |
| R10927 | Pilaralisib;SAR245408;XL147 | Pilaralisib (XL147) is a selective and reversible class I PI3K inhibitor for PI3 |
| R10929 | UNC1215 | UNC1215 is a potent and selective MBT (malignant brain tumor) antagonist, which |
| R10930 | Icotinib | Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM, including th |
| R10931 | Calcitriol; Vitamin D3 | Calcitriol is the hormonally active form of vitamin D. |
| R10934 | BI-847325 | BI-847325 is an orally bioavailable, and selective dual MEK/Aurora kinase inhibi |
| R10935 | AZD8186 | N/A |
| R10936 | FRAX597 | FRAX597 is a potent, ATP-competitive inhibitor of group I PAKs with IC50 of 8 nM |
| R10937 | AZD9496 | AZD9496 is a potent and selective estrogen receptor (ERα) antagonist with an IC5 |
| R10939 | BMS-911543 | BMS-911543 is a selective JAK2 inhibitor, with IC50s of 1.1 nM, less selective a |
| R10940 | PRT-060318;PRT318 | PRT-060318 (PRT318) is a novel selective inhibitor of the tyrosine kinase Syk wi |
| R10941 | Alectinib(CH5424802; RO5424802; AF802) | Alectinib (CH5424802) is a potent ALK inhibitor with IC50 of 1.9 nM in cell-free |
| R10942 | Binimetinib; MEK162,ARRY-162,ARRY-438162 | Binimetinib (MEK162, ARRY-162, ARRY-438162) is a potent inhibitor of MEK1/2 with |
| R10944 | MK-801 ; Dizocilpine | MK-801 (Dizocilpine) is a potent N-methyl-D-aspartate (NMDA) receptor antagonist |
| R10946 | Flibanserin;BIMT-17; BIMT-17BS | Flibanserin (BIMT-17) is a full agonist of the serotonin 5-HT1A receptor (Ki=1 n |
| R10948 | Lificiguat (YC-1) | Lificiguat binds to the β subunit of soluble guanylyl cyclase(sGC) with Kd of 0. |
| R10950 | ozanimod;RPC1063;RPC-1063 | Ozanimod (RPC1063) is a selective oral S1P Receptor 1 modulator. Phase 3. |
